Literature DB >> 6288399

Functional subsensitivity of alpha 2-adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment.

R M Cohen, C S Aulakh, I C Campbell, D L Murphy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288399     DOI: 10.1016/0014-2999(82)90614-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

Review 1.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

2.  Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation.

Authors:  C S Aulakh; R M Cohen; C McLellan; D L Murphy
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

3.  A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition.

Authors:  D O'Regan; R P Kwok; P H Yu; B A Bailey; A J Greenshaw; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats.

Authors:  J P Finberg; A Tal
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

5.  6-Hydroxydopamine pretreatment effects on alpha- and beta-adrenergic receptor adaptation to clorgyline.

Authors:  R M Cohen; C Aulakh; C McLellan; D L Murphy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

6.  Some effects of chronic antidepressant treatments on rat brain monoaminergic systems.

Authors:  M F Sugrue
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

7.  Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.

Authors:  J S Gutkind; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.